OT4B
The startup specializes in developing therapeutic services for Prader-Willi syndrome through the clinical application of oxytocin and its analogs, enhancing infants' feeding abilities and improving mother-child interactions. This approach aims to significantly enhance the daily lives of patients and their families by addressing the challenges associated with this genetic disorder.
- Biotechnology
- Digital Health
- Healthcare Technology
Updated 6 months ago
Funding
Raised to date
$11.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in developing therapeutic services for Prader-Willi syndrome through the clinical application of oxytocin and its analogs, enhancing infants' feeding abilities and improving mother-child interactions. This approach aims to significantly enhance the daily lives of patients and their families by addressing the challenges associated with this genetic disorder.